[Hyperthyroidism associated with hypopituitarism during the development of a TSH secreting pituitary tumor].
D000236:Adenoma / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000532:radiotherapy / Q000601:surgery; D000328:Adult; D002231:Carbimazole / Q000627:therapeutic use; D005246:Feedback; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007018:Hypopituitarism / Q000150:complications*; D010901:Pituitary Function Tests; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000601:surgery; D011859:Radiography; D013972:Thyrotropin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D002231:Carbimazole; D013972:Thyrotropin
Hyperthyroïdie associee á un hypopituitarisme au cours de l'evolution d'une tumeur hypophysaire secretant T.S.